Patients Breathing through barriers: Lived experience, innovation, an... When a disease runs in your family, you don’t learn about it from textbooks. You learn about it at funerals, in hospital beds, and emergency rooms.
Patients Mapping the crisis: How data can help fix America’s growing ... As major pharmacy chains like Walgreens continue to close hundreds of stores nationwide, pharmacy deserts are increasing across the US.
Patients The need for a science-first mindset: The vaccine landscape ... In a new pharmaphorum podcast, Rebecca Catterick, previously at Sanofi, discusses the decline in vaccination rates.
Patients Challenging conventional wisdom on injectables, with Mehul D... Mehul Desai, VP of medical affairs at Enable Injections, sat down with pharmaphorum editor-in-chief Jonah Comstock at AAPS.
Patients Start early - live well: Addressing the mental health crisis According to the World Health Organization (WHO), globally, one in seven 10-19-year-olds experiences a mental disorder, accounting for
Patients Real-world evidence in CNS research: Past, present, future Large-scale, multi-country real-world evidence (RWE) studies—including in Central Nervous System (CNS) indications—have the potential to deliver critical new insights.
R&D Precision, speed, impact: Evolving mass spectrometry for med... MOBILion's Melissa Sherman explores the evolving role of mass spectrometry in drug discovery, complex molecule analysis, and medical research.
Market Access The value of a partner, globally and locally A new podcast looks at recent trends related to drug approvals, as well as challenges and opportunities both small and large pharma companies face